ArticleCell reports. Medicine2022

Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.

Olivier Demaria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.